You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Business & Finance
Pharming receives shareholders' approval for share issue
3 February 2012 - Dutch biotech Pharming Group NV (AMS:PHARM) said today its shareholders had authorised at an extraordinary meeting the issue of 255m new shares.
The company's share capital will thus rise to 805m shares.
Pharming also said it had presented to the shareholders alternatives to deal with its negative equity situation. The company pointed it expects a milestone payment of up to USD15m (EUR11.5m) from successful finalisation of a US study.
Pharming announced last December a negative equity capital referring to among others changes needed to comply with the IFRS accounting requirements.
(USD1 = EUR0.764)
The company's share capital will thus rise to 805m shares.
Pharming also said it had presented to the shareholders alternatives to deal with its negative equity situation. The company pointed it expects a milestone payment of up to USD15m (EUR11.5m) from successful finalisation of a US study.
Pharming announced last December a negative equity capital referring to among others changes needed to comply with the IFRS accounting requirements.
(USD1 = EUR0.764)
Login
Related Headlines
Danaher Corporation announces quarterly cash dividend
Abbott announces quarterly common dividend
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva